CD47 and cancer: This mechanism is currently being exploited in studies on CD47 as a potential target for immunotherapeutics intending to augment immune-mediated destruction of cancer cells that overexpress CD477,8.The altered susceptibility of Cd47-deficient mice to inflammatory insults further suggest that CD47 expression is an important modulator of leukocyte function during pro-inflammatory immune responses9–14.